Corteva shares rally after Vylor spin‑off as analysts cut price targets
Corteva Inc. completed the spin‑off of its seed and genetics business into Vylor on October 1, 2026, separating roughly two‑thirds of its prior sales and EBITDA. The stock rebounded to $14.45, up about 15% in a week, while analysts such as Goldman Sachs, JPMorgan and others lowered their price targets to between $17 and $20. The company reported $17.40 billion in revenue with a 49.5% gross margin and is now valued at roughly 9.2‑10.5× forward EV/EBITDA.
Why it matters
Goldman Sachs’ new $20 target implies about 38% upside from the current price, indicating potential further gains for investors. The lower targets reflect the reduced size of Corteva after shedding its seed business, changing valuation multiples for the remaining crop‑protection operation.
Key facts
- 1Corteva spun off Vylor on October 1, 2026, representing about two‑thirds of its former sales and EBITDA. investing.com
- 2Corteva shares are trading at $14.45, a 15% gain over the past week. investing.com
- 3Goldman Sachs lowered its price target to $20.00 from $96.00 and kept a Buy rating. investing.com
- 4Goldman values Corteva at 10.5× EV/EBITDA and notes the stock trades at 9.2× EV/EBITDA on Q5‑Q8. investing.com
- 5Corteva reported revenue of $17.40 billion with a 49.5% gross margin. timothysykes.com
- 6Goldman projects $600 million of annual free cash flow for 2027‑2029. investing.com
Summary written by AlphAI from 2 of 2 sources. Not investment advice. Figures are as stated by the linked sources.